ASKA Pharmaceutical Holdings: License agreement on endometriosis with relugolix compounding agents in the field of gynecological diseases

JPX · May 31 14:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.